Latest Articles
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical - 아시아경제
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical 아시아경제
Published: April 2, 2026, 11:40 p.m.
Endometriosis Market: Rapid Growth & Investment Outlook to 2034 - DelveInsight - openPR.com
Endometriosis Market: Rapid Growth & Investment Outlook to 2034 - DelveInsight openPR.com
Published: April 2, 2026, 6:03 p.m.
Endometriosis Market: Rapid Growth & Investment Outlook to 2034 - DelveInsight - openpr.com
Endometriosis Market: Rapid Growth & Investment Outlook to 2034 - DelveInsight openpr.com
Published: April 2, 2026, 6:03 p.m.
DKSH Thailand and Bayer Thai Expand Strategic Partnership to Broaden Access to Endometriosis Treatment - newswit
DKSH Thailand and Bayer Thai Expand Strategic Partnership to Broaden Access to Endometriosis Treatment newswit
Published: April 2, 2026, 2:01 p.m.
Press conference with Assistant Minister White, Melbourne – 2 April 2026 - Australian Government Department of Health, Disability and Ageing
Press conference with Assistant Minister White, Melbourne – 2 April 2026 Australian Government Department of Health, Disability and Ageing
Published: April 2, 2026, 2:24 a.m.
Support for former patients of Simon Gordon - Australian Government Department of Health, Disability and Ageing
Support for former patients of Simon Gordon Australian Government Department of Health, Disability and Ageing
Published: April 1, 2026, 9:31 p.m.
Trans advocate Steph Richards blames 'transphobia' for backlash after endometriosis charity appointment - scenemag.co.uk
Trans advocate Steph Richards blames 'transphobia' for backlash after endometriosis charity appointment scenemag.co.uk
Published: April 1, 2026, 11:54 a.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - Femtech Insider
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment Femtech Insider
Published: April 1, 2026, 11:54 a.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - femtechinsider.com
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment femtechinsider.com
Published: April 1, 2026, 11:54 a.m.
Trans advocate Steph Richards pushes back against backlash after endometriosis charity appointment - scenemag.co.uk
Trans advocate Steph Richards pushes back against backlash after endometriosis charity appointment scenemag.co.uk
Published: April 1, 2026, 11:50 a.m.
Link copied to clipboard!